

Our projections show the substantial detrimental impacts that cuts to PEPFAR funding could have. Mitigation measures, including funding through alternative international donors or domestic government budgets, are needed to maintain and increase existing coverage levels of PrEP and therefore prevent the detrimental impact of PEPFAR's funding cuts, particularly in high coverage countries.
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet
HIV
|15th Jan, 2026
|The Lancet